Arbutus Biopharma (ABUS) Leases (2019 - 2024)
Historic Leases for Arbutus Biopharma (ABUS) over the last 6 years, with Q4 2024 value amounting to $1.0 million.
- Arbutus Biopharma's Leases fell 2598.87% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 2598.87%. This contributed to the annual value of $1.0 million for FY2024, which is 2598.87% down from last year.
- According to the latest figures from Q4 2024, Arbutus Biopharma's Leases is $1.0 million, which was down 2598.87% from $1.1 million recorded in Q3 2024.
- Arbutus Biopharma's Leases' 5-year high stood at $2.7 million during Q1 2020, with a 5-year trough of $1.0 million in Q4 2024.
- For the 5-year period, Arbutus Biopharma's Leases averaged around $1.9 million, with its median value being $1.9 million (2022).
- Per our database at Business Quant, Arbutus Biopharma's Leases crashed by 1123.75% in 2020 and then tumbled by 2598.87% in 2024.
- Quarter analysis of 5 years shows Arbutus Biopharma's Leases stood at $2.4 million in 2020, then decreased by 13.01% to $2.1 million in 2021, then decreased by 16.63% to $1.7 million in 2022, then fell by 18.81% to $1.4 million in 2023, then fell by 25.99% to $1.0 million in 2024.
- Its last three reported values are $1.0 million in Q4 2024, $1.1 million for Q3 2024, and $1.2 million during Q2 2024.